| Eye
Involvement |
|
|
|
|
| These symptoms
may sometimes occur in systemic
sclerosis (scleroderma). Scleroderma (SD) affects everyone
differently. Just because something is listed here does not
mean it is caused by scleroderma nor that an individual scleroderma
patient will ever experience it. See Disclaimer. |
| What is Normal Tension
Glaucoma (NTG)? |
| What
is Glaucoma? Glaucoma is a group of eye diseases that
gradually steals sight without warning and often without
symptoms. Glaucoma Research Foundation. |
A
Patient Guide to Ocular Inflammatory Disease. This is
an online guide, covering symptoms, diagnosis and treatment
for inflammatory eye diseases. In addition, printed copies
of this guide can be requested free of charge from the Ocular
Immunology and Uveitis Foundation. (Also see: Dr.
C. Stephen Foster, ISN Medical Advisory Board) |
| Glaucomatous
Type Abnormalities in Patients with Systemic Sclerosis. Glaucomatous
type abnormalities were more frequent in patients with SSc
compared to the control group. Such abnormalities may be
attributed to the vasculopathy that is observed in patients
with SSc, affecting the vessels of the optic disc. G.
Kitsos. FRI0347 EULAR 2006. |
| Eye Involvement in
Scleroderma (Systemic Sclerosis) |
| Eye symptoms and diseases that may be related
to scleroderma, including Normal Tension Glaucoma and Autoimmune
Iritis or Uveitis. ISN |
| Sclerokeratitis and facial skin lesions: a case report of pyoderma gangrenosum and its response to dapsone therapy. Pyoderma gangrenosum is a rare autoimmune disorder that can affect the eye. Biopsy of affected tissue is the key to diagnosis. Immunomodulating therapy can be a useful adjunct to the traditional steroid therapy. PubMed. Cornea 2007 Feb;26(2):215-9. |
| Proliferative vascular retinopathy in polymyositis and dermatomyositis with scleroderma (overlap syndrome). Retinal vascular occlusion with development of proliferative changes can occur in polymyositis/dermatomyositis. PubMed. Ocul Immunol Inflamm. 2007 Jan-Feb;15(1):45-9. (Also see: Overlap Syndrome and Polymyositis/Dermatomyositis) |
| Therapy
insight: The recognition and treatment of retinal manifestations
of systemic vasculitis. A variety of retinal signs can
occur in patients who have systemic vasculitides, or who
experience complications of these diseases or their treatment.
Although treatment of these retinal manifestations is usually
the treatment of the systemic disease, specific treatment
is occasionally indicated to preserve vision. PubMed.
Nat Clin Pract Rheumatol. 2006 Aug;2(8):443-51. (Also see: Vasculitis) |
| Ophthalmological
involvement in rheumatic disease. The main conclusion
of our study is that rheumatic patients need to be referred
to an ophthalmologist for the diagnosis and the optimal treatment
of ocular involvement. PubMed. Oftalmologia. 2006;50(2):56-61. |
| Laser
in situ keratomileusis (LASIK) in patients with autoimmune
diseases. Laser in situ keratomileusis may be a reasonable
option in patients with well-controlled or inactive autoimmune
disease. PubMed. J Cataract Refract Surg. 2006 Aug;32(8):1292-5. |
A
significant increase of normal tension glaucoma (NTG) has
been discovered in patients with systemic scleroderma. In
a 2003
study of 88 scleroderma patients in France, 10 of the
patients were found to have NTG, compared to none of the
controls.
Pellucid
marginal degeneration and scleroderma. Pellucid marginal
degeneration is characterised by non-inflammatory and progressive
peripheral corneal thinning inferiorly, often with high
against-the-rule astigmatism. We report a case of a 55-year-old
woman with systemic scleroderma who presented with rapidly
progressing against-the-rule astigmatism. PubMed. Clin
Exp Optom. 2004 May;87(3):180-4. |
| Increased
prevalence of ocular glaucomatous abnormalities in systemic
sclerosis. Ocular abnormalities suggesting glaucomatous
neuropathy without ocular hypertension were dramatically
more prevalent in patients with SSc. These abnormalities
seem to be mild but justify long term follow up. They are
consistent with the vascular pathogenic hypothesis for NTG
(normal tension glaucoma).PubMed. Ann Rheum Dis. 2004
Oct;63(10):1276-8. |
| Investigations
for retinopathy in an avian model for systemic sclerosis. Our
data raise serious doubts about primary posterior ocular
involvement in human SSc. However, fundal examinations in
patients with SSc may have their justification for assessment
of hypertensive retinopathy. PubMed. Exp Eye Res. 2004
Jul;79(1):85-92. |
| Retinal
findings in systemic sclerosis: a comparison with nailfold
capillaroscopic patterns. Retinal abnormalities are often
seen in patients with SSc and they may reflect the vascular
changes characteristic of SSc. Ann Rheum Dis. 2003 Mar;62(3):204-7. |
| Increased
Incidence of Normal Tension Glaucoma (NTG) in Systemic Sclerosis
(SSc). NTG is dramatically increased in SSc compared
to patients with osteoarthritis. These results might have
important clinical implications in SSc and justify long-term
follow-up to assess the possible ophthalmological risk. They
are also consistent with the vascular pathogenic hypothesis
for NTG. Y. Allanore. FRI0077 EULAR 2003. |
| Scleroderma,
stroke, optic neuropathy: a rare association. A known
case of scleroderma presented with right hemiparesis, focal
seizures, optic atrophy and gangrene of digits. MRI showed
multifocal infarcts in both cerebral hemispheres. The rarity
of central nervous system affliction in scleroderma and large
vessel vasculitis is discussed along with review of literature. PubMed.
Neurol India 2002 Dec;50(4):504-7. (Also see: Cardiac
Involvement: Stroke) |
| Symptoms and Diagnosis
of Normal Tension Glaucoma |
| Symptoms
of Normal Tension Glaucoma. Regular eye examinations
with an ophthalmologist are important to screen for optic
nerve damage and vision loss despite a normal eye pressure. eMedicine. |
| Antiphospholipid
antibodies in patients with sensorineural hearing loss. Sensorineural
hearing loss can be associated with autoimmune diseases and
the presence of antiphospholipid antibodies. Our data suggest
that antibodies against beta(2)-glycoprotein seem to coincide
with an acute event, such as sudden sensorineural hearing
loss, whereas antibodies against phosphatidylserine IgG are
detectable in the prolonged sequel, such as in patients with
progressive sensorineural hearing loss and normal tension
glaucoma. PubMed. Eur Arch Otorhinolaryngol. 2005 Feb
25. (Also see: Antiphospholipid
Syndrome and Ear
Involvement) |
| Treatments of Normal
Tension Glaucoma |
| Therapy-resistant inflammatory glaucoma responds to transscleral red laser cyclophotocoagulation. More than one treatment was needed in 52% of eyes, but no cases of hypotony, phthisis bulbi or other complications occurred. OSN Supersite. 09/04/07. |
| Effect
of sex hormones on experimental autoimmune uveoretinitis
(EAU). The data support the hypothesis that sex hormones
may affect autoimmune diseases by inducing changes in the
cytokine balance. This suggests that sex hormone therapy
could be considered as an adjunct to anti-inflammatory agents
to treat ocular autoimmune diseases in humans. PubMed.
Immunol Invest. 2003 Nov;32(4):259-73. |
| Retinal
findings in systemic sclerosis: a comparison with nailfold
capillaroscopic patterns. Retinal abnormalities are often
seen in patients with SSc and they may reflect the vascular
changes characteristic of SSc. However, retinal changes may
differ in quality from the changes of nailfold capillaries. PubMed.
Ann Rheum Dis 2003 Mar;62(3):204-7. (Also see: Types
of Scleroderma) |
| Autoimmune Iritis
or Uveitis (Eye Inflammation) |
| Autoimmune
optic neuropathy. This review considers optic neuropathy
that occurs as part of recognized systemic autoimmune disorders
and collagen vascular diseases and isolated autoimmune optic
neuropathy. PubMed. Curr Neurol Neurosci Rep. 2006 Sep;6(5):396-402. |
| Help
for inflammatory eye disease. Inflammatory Eye Diseases
(the most common being scleritis and uveitis) are the fifth-leading
cause of blindness in the United States. Prednisone is the
common treatment. Now, CellCept—a drug used to prevent
organ transplant rejection —can treat eye inflammation and
get patients on lower doses of, or even off, prednisone. Ivanhoe
Broadcast News 02-20-06. |
| Uveitis
in the internist's office: are a patient's eye symptoms serious? If
the diagnosis of uveitis is made, internists must search
for an underlying cause, such as infection or an autoimmune
disease. PubMed. Cleve Clin J Med. 2005 Apr;72(4):329-39. |
| Intraocular
inflammation in autoimmune diseases. An underlying autoimmune
disease was identified in up to 40% of patients with intraocular
inflammation (IOI). Immunosuppressive drugs, biologic agents,
and IVIG (intravenous immunoglobulin) are employed for the
treatment of IOI in autoimmune diseases. PubMed. Semin
Arthritis Rheum. 2004 Dec;34(3):602-9. |
| Prevalence
of the Spondyloarthritides in Patients with Uveitis. Uveitis
is associated not only with AS and reactive arthritis, but
also with undifferentiated spondyloarthritis and psoriatic
arthritis. J Rheumatol. November 2004;31:2226-9. |
| Type
I collagen is the autoantigen in experimental autoimmune
anterior uveitis. Although human anterior uveitis has
been historically characterized as a collagen disease, this
is first time collagen has been directly identified as the
target autoantigen in uveitis. PubMed. J Immunol. 2004
Jun 1;172(11):7086-94. |
| Sulfasalazine
Reduces the Number of Flares of Acute Anterior Uveitis Over
a One-Year Period. The mean number of flares in the pre-SSZ
year was 3.4, which was significantly reduced to 0.9 in the
year of treatment. J Rheumatol NO. 6 JUNE 2003;30:1277-9. |
| Granulomatous
uveitis, CREST syndrome, and primary biliary cirrhosis. Our
case report illustrates an association between ocular and
hepatic diseases, which may be entirely coincidental but
could, nevertheless, encourage further investigation for
a common immunological pathway. Br J Ophthalmol 2000;84:546.
(Also see: CREST
Syndrome and Liver
Involvement) |
| Support Groups for
Eye Diseases |
| Uveitis
Online Support Group C. Stephen Foster, M.D.,
Medical Advisor. |
| Uveitis
Glossary. Ocular Immunology and Uveitis Foundation,
Cambridge, MA USA. |
| Harvard
University / Ocular Immunology and Uveitis Foundation. Extensive
patient support forums, glossary, articles, support
community. Ocular Immunology and Uveitis Foundation,
Cambridge, MA USA. |
| Uveitis
Kids. This is a resource website for kids only
and they have access to an online support group page
there as well. Ocular Immunology and Uveitis Foundation,
Cambridge, MA USA. |
| Uveitis
Support . International online support community
for anyone living with ocular inflammatory disease. Ocular
Immunology and Uveitis Foundation, Cambridge, MA USA. |
| Uveitis
Information Group The UIG is a UK based organization
devoted to providing easily understood patient information
and support. UIG. |
|
| Eye Involvement Patient and Caregiver Stories |
| Tata P: Diffuse Scleroderma I am thirty-two years old, and I have been suffering
this illness since I was nine... |
| (Español/Spanish) Tata P: Esclerodermia Difusa Hola,
tengo 32 años, y padezco esta enfermedad desde los
9... |
| Related Pages |
| Dr.
C. Stephen Foster: ISN Medical Advisory Board. Dr. Foster
is Clinical Professor of Ophthalmology at Harvard Medical
School and Director of the Ocular Immunology and Uveitis
Foundation in Cambridge, MA USA. ISN. |
| Cataracts Surgery and Scleroderma? Ask Dr. Foster Forum. |
| Sjogren's
Syndrome A systemic autoimmune disease that sometimes
occurs in overlap with systemic sclerosis (scleroderma) and
causes dryness of the eyes, mouth and skin. ISN. |
| Media Stories and
Research |
| LASIK
in Patients with Rheumatic Diseases A Pilot Study. In
this small series, we found good outcomes when correcting
refractive errors using LASIK in selected patients with controlled
rheumatic diseases. In this series, a favorable postoperative
visual outcome was obtained with no operative or postoperative
vision-threatening complications. PubMed. Ophthalmology.
2005 Sep 14. |
| A
Protein in the Eye May Prevent Immune Response and Protect
Eyes from Disease. A protein known as F4/80 found on
immune cells in the eye and other parts of the body may have
a function in the regulation of the body's immune response
and protect delicate tissues that cannot survive the "inflammation" inherent
in full-blown immunity. redorbit News. 06/21/05. |